Looking Ahead to the Future of Multiple Myeloma Treatment

EP: 1.Breakthroughs in Therapeutic Options for Relapsed/Refractory Multiple Myeloma

EP: 2.Highlights From the 2021 European Hematology Association Congress on Multiple Myeloma

EP: 3.Upcoming Abstracts on Multiple Myeloma for Presentation at 2021 ASH

EP: 4.Biggest FDA News for Multiple Myeloma in 2021

EP: 5.Treatment Options for Transplant-Eligible Multiple Myeloma

EP: 6.Treatment Options for Transplant-Ineligible Multiple Myeloma

EP: 7.Navigating Individual Treatment for Relapsed/Refractory Multiple Myeloma

EP: 8.Understanding Adverse Events in Multiple Myeloma

EP: 9.BCMA-Directed Agents for Multiple Myeloma

EP: 10.Optimal Therapies for Relapsed/Refractory Multiple Myeloma

EP: 11.Emerging Research and Therapies for Multiple Myeloma

EP: 12.Upcoming Phase 3 Data in Multiple Myeloma

EP: 13.Trials Evaluating Emerging Maintenance Therapy Regimens in Multiple Myeloma

Now Viewing

EP: 14.Looking Ahead to the Future of Multiple Myeloma Treatment

EP: 15.Current Leading Therapies for Multiple Myeloma

Nina Shah, MD: As we move forward in multiple myeloma, I’m excited to see longer term follow-up data for the immunotherapy trials because it’s important for us to know what kind of duration of response our patients are going to get. I am interested in seeing quality of life data because I want to know how to choose between these modalities, which may not be the best for one patient versus another, or what may be best suited for all patients. I also want to see how we’re incorporating minimal residual disease [MRD] for decision making. For that, we’ll look to trials like the MASTER trial [NCT03224507]. Finally, I’m really excited to see if there’s some way that we could get blood-based MRD testing, which is already being looked at with mass spectrometry and other technologies, because I would love for patients to be able to avoid bone marrow [biopsies]. I hate ordering them and patients hate getting them and it’d be great if we could use something else to detect disease and detect it early.